(Q46288519)

21 December 2017

title

Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease (English)

1 reference

21 December 2017

Mycobacterium avium avium

main subject

1 reference

Phung K Lam

1

1 reference

21 December 2017

David E Griffith

2

1 reference

21 December 2017

Timothy R Aksamit

3

1 reference

21 December 2017

Stephen J Ruoss

4

1 reference

21 December 2017

Stuart M Garay

5

1 reference

21 December 2017

Charles L Daley

6

1 reference

21 December 2017

Antonino Catanzaro

7

1 reference

21 December 2017

language of work or name

English

0 references

publication date

2 March 2006

1 reference

21 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

21 December 2017

volume

173

1 reference

21 December 2017

issue

11

1 reference

21 December 2017

page(s)

1283-1289

1 reference

21 December 2017

Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200509-1531OC

Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200509-1531OC

Medical management of pulmonary disease caused by Mycobacterium avium complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200509-1531OC

Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200509-1531OC

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200509-1531OC

A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency sy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200509-1531OC

Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200509-1531OC

Diagnosis, differentiating colonization, infection, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200509-1531OC

Epidemiology of human pulmonary infection with nontuberculous mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200509-1531OC

Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200509-1531OC

Mycobacterium avium complex pulmonary disease in patients without HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200509-1531OC

10.1164/RCCM.200509-1531OC

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017